Израиль - английский - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone furoate; umeclidinium as bromide; vilanterol as trifenatate - powder for inhalation pre-dispensed - vilanterol as trifenatate 22 mcg/inh; umeclidinium as bromide 55 mcg/inh; fluticasone furoate 92 mcg/inh - vilanterol, umeclidinium bromide and fluticasone furoate - asthmatrelegy ellipta 92/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older.trelegy ellipta 92/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ics/laba.important limitations of use:trelegy ellipta 92/55/22 mcg is not indicated for the relief of acute asthma.copd (chronic obstructive pulmonary disease)trelegy ellipta 92/55/22 mcg is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist or a combination of a long-acting β2-agonist and a long-acting muscarinic antagonist.

Израиль - английский - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone furoate; umeclidinium as bromide; vilanterol as trifenatate - powder for inhalation pre-dispensed - vilanterol as trifenatate 22 mcg/inh; umeclidinium as bromide 55 mcg/inh; fluticasone furoate 184 mcg/inh - vilanterol, umeclidinium bromide and fluticasone furoate - asthmatrelegy ellipta 184/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older. trelegy ellipta 184/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ics/laba.important limitations of usetrelegy ellipta 184/55/22 mcg is not indicated for the relief of acute asthma.trelegy ellipta 184/55/22 mcg is not indicated for patients with copd.

Соединенные Штаты - английский - NLM (National Library of Medicine)

remedyrepack inc. - fluticasone furoate (unii: js86977wnv) (fluticasone - unii:cut2w21n7u), vilanterol trifenatate (unii: 40aho2c6dg) (vilanterol - unii:028lzy775b) - breo ellipta 100/25 is indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. breo ellipta 100/25 is also indicated to reduce exacerbations of copd in patients with a history of exacerbations. breo ellipta 100/25 once daily is the only strength indicated for the treatment of copd. important limitation of use breo ellipta is not indicated for the relief of acute bronchospasm. breo ellipta is indicated for the once-daily treatment of asthma in patients aged 18 years and older. breo ellipta should be used for patients not adequately controlled on a long-term asthma control medication such as an inhaled corticosteroid (ics) or whose disease warrants initiation of treatment with both an ics and long-acting beta 2 -adrenergic agonist (laba). important limitation of use breo ellipta is not indicated for the relief of acute bronchospasm. the use of breo ellipta is

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - fluticasone furoate; vilanterol - inhalation powder - 184microgram/1dose ; 22microgram/1dose

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - fluticasone furoate; vilanterol - inhalation powder - 92microgram/1dose ; 22microgram/1dose

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - fluticasone furoate; vilanterol - inhalation powder - 184microgram/1dose ; 22microgram/1dose

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - fluticasone furoate; vilanterol - inhalation powder - 92microgram/1dose ; 22microgram/1dose

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - fluticasone furoate; vilanterol - inhalation powder - 184microgram/1dose ; 22microgram/1dose

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - fluticasone furoate; vilanterol - inhalation powder - 92microgram/1dose ; 22microgram/1dose

Япония - английский - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - fluticasone furoate - white uniformly suspended solution for nasal spray, color of container: (bottle) white, (cap) blue